A roundup of all the latest news on www.globaluniversityventuring.com for our subscribers.

Torigen vaccinates $3.1m series A
Building on research by a former University of Minnesota professor, Torigen Pharmaceuticals has begun in-veterinary testing of its immunooncology vaccine for companion animals.
Recida rolls out from Frazier Healthcare
Venture capital firm Frazier Healthcare Partners has spun out a US-based antibiotics developer with the help of grant funding from a Boston University-operated body and a $8.5m series A round.
IU commences dig at the Quarry
Indiana University…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?